Clinical trials
Phase 1 Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
114 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 10 |
| 2018 | 4 |
| 2019 | 8 |
| 2020 | 9 |
| 2021 | 8 |
| 2022 | 12 |
| 2023 | 9 |
| 2024 | 12 |
| 2025 | 7 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Terminated | 23 |
| Recruiting | 20 |
| Active, not recruiting | 12 |
| Unknown status | 9 |
| Withdrawn | 7 |
| Not yet recruiting | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 6 |
| Eli Lilly and Company | 5 |
| Mayo Clinic | 4 |
| Celldex Therapeutics | 3 |
| Jonsson Comprehensive Cancer Center | 3 |
| AbbVie | 2 |
| Chongqing Precision Biotech Co., Ltd | 2 |
| City of Hope Medical Center | 2 |
| Hutchmed | 2 |
| MacroGenics | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 114 |
| Colorectal Neoplasms | 35 |
| Pancreatic Neoplasms | 32 |
| Stomach Neoplasms | 30 |
| Carcinoma, Non-Small-Cell Lung | 26 |
| Ovarian Neoplasms | 25 |
| Breast Neoplasms | 19 |
| Esophageal Neoplasms | 19 |
| Carcinoma, Hepatocellular | 18 |
| Melanoma | 17 |
Trials
Showing 26 to 50 of 114. Each trial links to its page on Pharma Observatory.
14 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.